Area: Precision Medicine
Booth No: M328
BioMab, Inc. is an immune-based precision medicine company based in Taiwan. Spun-out of Academia Sinica, our current product portfolio focuses on two primary areas of precision medicine: circulating tumor cell (CTC) detection and autologous natural killer cell immunotherapy. Our CTC enrichment kit is based on positive selection of EpCAM positive cells in blood or other body fluid. DSNK kit features simple work flow high NK cell expansion rate ( 1500x ~3000x) and high target cell purity (>90%).
Exhibitors you may be interested in